Finch Therapeutics Group, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Finch Therapeutics Group, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2016 to Q2 2024.
  • Finch Therapeutics Group, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $25.4M, a 6.84% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $25.4M -$1.87M -6.84% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $26M -$5.81M -18.3% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $26.6M -$6.17M -18.8% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 $26.6M -$13.8M -34.1% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $27.3M -$13.9M -33.7% Jun 30, 2023 10-Q/A 2023-08-11
Q1 2023 $31.8M +$27M +562% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $32.8M +$27.7M +548% Dec 31, 2022 10-K 2024-03-25
Q3 2022 $40.4M +$35.1M +661% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $41.2M +$35.7M +649% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $4.81M -$989K -17.1% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $5.05M +$5.05M Dec 31, 2021 10-K 2023-03-23
Q3 2021 $5.3M Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $5.5M Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $5.8M Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $0 Dec 31, 2020 10-K 2022-03-31
Q1 2016 $5.8M Feb 29, 2016 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.